ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics Stock Forecast

Stock Price Forecast

According to 7 professional analysts, the 12-month price target for ProQR Therapeutics stock ranges from a low of $4.00 to a high of $12. The average analyst price target of $8.14 forecasts a 289.47% increase in the stock price over the next year.

Price Target: $8.14 (+289.47%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$8.14	$8.00	$12
Change	+91.39%	+289.47%	+282.78%	+474.16%

* Price targets were last updated on Nov 4, 2025.

Analyst Ratings

The average analyst rating for ProQR Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	4	4	4	4	3	3
Buy	4	4	4	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $4	Strong Buy	Maintains	$4	+91.39%	Nov 4, 2025
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $4	Strong Buy	Maintains	$4	+91.39%	Aug 8, 2025
Timur Ivannikov Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $8	Buy	Reiterates	$8	+282.78%	Jun 27, 2025
Jonathan Wolleben JMP Securities	JMP Securities	Buy Reiterates $8	Buy	Reiterates	$8	+282.78%	Jun 27, 2025
Andreas Argyrides Oppenheimer	Oppenheimer	Buy Maintains $15 → $9	Buy	Maintains	$15 → $9	+330.62%	May 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

15.38M

Decreased by -21.32%

from 19.55M

Revenue Next Year

13.07M

Decreased by -15.00%

from 15.38M

EPS This Year

-0.43

from -0.32

EPS Next Year

-0.55

from -0.43

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.03M	2.38M	4.36M	6.59M	19.55M	15.38M	13.07M
Revenue Growth	-46.77%	131.10%	83.30%	51.27%	196.41%	-21.32%	-15.00%
EPS	-0.93	-0.95	-0.90	-0.35	-0.32	-0.43	-0.55
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	10

Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	22.7M	23.2M
Avg	15.4M	13.1M
Low	11.0M	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	15.9%	50.6%
Avg	-21.3%	-15.0%
Low	-43.8%	-

EPS Forecast

EPS	2025	2026	2027
High	-0.28	-0.34
Avg	-0.43	-0.55
Low	-0.53	-0.79

EPS Growth

EPS Growth	2025	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.